Ovarian tumors of low malignant potential.

Current treatment options in oncology

Volumn 2, Issue 2, 2001, Pages 103-108

  Trimble, Edward L ^a,b   Trimble, Cornelia L ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; FERTILITY; HUMAN; OVARY CYST; PATHOLOGY; PRACTICE GUIDELINE; PROGNOSIS; REVIEW;

FEMALE; FERTILITY; HUMANS; OVARIAN CYSTS; PRACTICE GUIDELINES; PROGNOSIS;

EID: 0035322793     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-001-0052-2     Document Type: Review

References (32)

1. 1. J Prat 1999 Ovarian tumors of borderline malignancy (tumors of low malignant potential): a critical appraisal Adv Anat Pathol 6 247 274 10472378 10.1097/00125480-199909000-00002 1:STN:280:DyaK1MvgtFGqug%3D%3D Comprehensive review of the various histopathologic entities previously classified as ovarian tumors of LMP. Prat J: Ovarian tumors of borderline malignancy (tumors of low malignant potential): a critical appraisal. Adv Anat Pathol 1999, 6:247–274. Comprehensive review of the various histopathologic entities previously classified as ovarian tumors of LMP.
2. 2. DM Gershenson EG Silva L Levy 1998 Ovarian serous borderline tumors with invasive peritoneal implants Cancer 82 1096 1103 9506355 10.1002/(SICI)1097-0142(19980315)82:6<1096::AID-CNCR13>3.0.CO;2-1 1:STN:280:DyaK1c7msFWkug%3D%3D Gershenson DM, Silva EG, Levy L, et al.: Ovarian serous borderline tumors with invasive peritoneal implants. Cancer 1998, 82:1096–1103.
3. 3. RT Burks ME Sherman RJ Kurman 1996 Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors Am J Surg Pathol 20 1319 1330 8898836 10.1097/00000478-199611000-00003 1:STN:280:DyaK2s%2FlsVGguw%3D%3D Burks RT, Sherman ME, Kurman RJ: Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 1996, 20:1319–1330.
4. 4. JH Eichhorn DA Bell RH Young 1999 Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns Am J Surg Pathol 23 397 409 10199469 10.1097/00000478-199904000-00004 1:STN:280:DyaK1M3htlGlsw%3D%3D Eichhorn JH, Bell DA, Young RH, et al.: Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol 1999, 23:397–409.
5. 5. M Dietel S Hauptmann 2000 Serous tumors of low malignant potential of the ovary. I. Diagnostic pathology Virchows Arch 436 403 412 10881733 10.1007/s004280050467 1:STN:280:DC%2BD3czjvVKnsA%3D%3D Dietel M, Hauptmann S: Serous tumors of low malignant potential of the ovary. I. Diagnostic pathology. Virchows Arch 2000, 436:403–412.
6. 6. BM Ronnett BM Shmookler PH Sugarbaker 1997 Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary Anat Pathol 2 197 226 9575376 1:STN:280:DyaK1c3js1arug%3D%3D Ronnett BM, Shmookler BM, Sugarbaker PH, et al.: Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary. Anat Pathol 1997, 2:197–226.
7. 7. MA Riopel BM Ronnett RJ Kurman 1999 Evaluation of diagnostic criteria and behavior of ovarian intestinaltype mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas Am J Surg Pathol 23 617 635 10366144 10.1097/00000478-199906000-00001 1:STN:280:DyaK1M3pt1altA%3D%3D Riopel MA, Ronnett BM, Kurman RJ: Evaluation of diagnostic criteria and behavior of ovarian intestinaltype mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. Am J Surg Pathol 1999, 23:617–635.
8. 8. WD Lawrence 1995 The borderland between benign and malignant surface epithelial ovarian tumors. Current controversy over the nature and nomenclature of ’borderline’ ovarian tumors Cancer 76 2138 2142 8635013 10.1002/1097-0142(19951115)76:10+<2138::AID-CNCR2820761338>3.0.CO;2-U 1:STN:280:DyaK283ivF2ruw%3D%3D Lawrence WD: The borderland between benign and malignant surface epithelial ovarian tumors. Current controversy over the nature and nomenclature of ’borderline’ ovarian tumors. Cancer 1995, 76 (suppl):2138–2142.
9. 9. WH Gotleib E Friedman RB Bar-Sade 1998 Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors J Natl Cancer Inst 90 995 1000 10.1093/jnci/90.13.995 Gotleib WH, Friedman E, Bar-Sade RB: Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors. J Natl Cancer Inst 1998, 90:995–1000.
10. 10. KH Lu DW Cramer MG Muto 1999 A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer Obstet Gynecol 93 34 37 9916952 10.1016/S0029-7844(98)00362-7 1:CAS:528:DyaK1MXmsVantg%3D%3D Lu KH, Cramer DW, Muto MG: A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer. Obstet Gynecol 1999, 93:34–37.
11. 11. R Harris AS Whittemore J Itnyre 1992 Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group Am J Epidemiol 136 1204 1211 1476142 1:STN:280:DyaK3s7hvVKgtg%3D%3D Harris R, Whittemore AS, Itnyre J: Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992, 136:1204–1211.
12. 12. LL McCluskey LL Dubeau 1997 Biology of ovarian cancer Curr Opin Oncol 9 465 470 9327225 1:STN:280:DyaK2svmvVSrsw%3D%3D 10.1097/00001622-199709050-00011 Review article that sets out the molecular evidence which distinguishes LMP tumors from epithelial ovarian carcinoma. McCluskey LL, Dubeau LL: Biology of ovarian cancer. Curr Opin Oncol 1997, 9:465–470. Review article that sets out the molecular evidence which distinguishes LMP tumors from epithelial ovarian carcinoma.
13. 13. KH Lu DA Bell WR Welch 1998 Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors Cancer Res 58 2328 2330 9622067 1:CAS:528:DyaK1cXjs12ru7o%3D Lu KH, Bell DA, Welch WR, et al.: Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors. Cancer Res 1998, 58:2328–2330.
14. 14. RG Caduff SM Svoboda-Newman AW Ferguson 1999 Comparison of mutations of Ki-ras and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors Am J Surg Pathol 23 323 328 10078924 10.1097/00000478-199903000-00012 1:STN:280:DyaK1M7ns1yisg%3D%3D Caduff RG, Svoboda-Newman SM, Ferguson AW, et al.: Comparison of mutations of Ki-ras and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors. Am J Surg Pathol 1999, 23:323–328.
15. 15. MR Evans IW McDicken CS Herrington 1999 Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumors J Pathol 189 53 59 10451488 10.1002/(SICI)1096-9896(199909)189:1<53::AID-PATH393>3.0.CO;2-U 1:STN:280:DyaK1Mzot1Cjuw%3D%3D Evans MR, McDicken IW, Herrington CS, et al.: Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumors. J Pathol 1999, 189:53–59.
16. 16. T Bjorge A Engeland S Hansen 1998 Prognosis of patients with ovarian cancer and borderline tumors diagnosed in Norway between 1954 and 1993 Int J Cancer 75 663 670 9495231 10.1002/(SICI)1097-0215(19980302)75:5<663::AID-IJC1>3.0.CO;2-X 1:STN:280:DyaK1c7lsVKiuw%3D%3D Long-term population-based follow-up data on LMP tumors. Bjorge T, Engeland A, Hansen S, et al.: Prognosis of patients with ovarian cancer and borderline tumors diagnosed in Norway between 1954 and 1993. Int J Cancer 1998, 75:663–670. Long-term population-based follow-up data on LMP tumors.
17. 17. JD Seidman RJ Kurman 2000 Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators Hum Pathol 31 539 557 10836293 10.1053/hp.2000.8048 1:STN:280:DC%2BD3c3psVarsA%3D%3D Meta-analysis of 97 studies including 4129 women with serous tumors of LMP. Seidman JD, Kurman RJ: Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 2000, 31:539–557. Meta-analysis of 97 studies including 4129 women with serous tumors of LMP.
18. 18. EL Yeo KM Yu MC Poddar 1998 The accuracy of intraoperative frozen section in the diagnosis of ovarian tumors J Obstet Gynaecol Res 24 189 915 9714989 1:STN:280:DyaK1czotVOhsw%3D%3D 10.1111/j.1447-0756.1998.tb00074.x Yeo EL, Yu KM, Poddar MC, et al.: The accuracy of intraoperative frozen section in the diagnosis of ovarian tumors. J Obstet Gynaecol Res 1998, 24:189–915.
19. 19. K Houck N Nikrui L Duska 2000 Borderline tumors of the ovary: correlation of frozen and permanent histopathologic diagnosis Obstet Gynecol 95 839 843 10831977 10.1016/S0029-7844(99)00656-0 1:STN:280:DC%2BD3czisFersw%3D%3D Houck K, Nikrui N, Duska L, et al.: Borderline tumors of the ovary: correlation of frozen and permanent histopathologic diagnosis. Obstet Gynecol 2000, 95:839–843.
20. 20. F Kayicioglu O Pata S Cengiz 2000 Accuracy of frozen section diagnosis in borderline ovarian malignancy Gynecol Obstet Invest 49 187 189 10.1159/000010244 Kayicioglu F, Pata O, Cengiz S, et al.: Accuracy of frozen section diagnosis in borderline ovarian malignancy. Gynecol Obstet Invest 2000, 49:187–189.
21. 21. E Darai J Teboul A Fauconnier 1998 Management and outcome of borderline ovarian tumors incidentally discovered at or after laparoscopy Acta Obstet Gynecol Scand 77 451 457 9598957 10.1034/j.1600-0412.1998.770417.x 1:STN:280:DyaK1c3lvV2jtg%3D%3D Darai E, Teboul J, Fauconnier A, et al.: Management and outcome of borderline ovarian tumors incidentally discovered at or after laparoscopy. Acta Obstet Gynecol Scand 1998, 77:451–457.
22. 22. E Malik W Bohm F Stoz 1998 Laparoscopic management of ovarian tumors Surg Endosc 12 1326 1333 9788856 10.1007/s004649900850 1:STN:280:DyaK1M%2FgsFCktQ%3D%3D Malik E, Bohm W, Stoz F, et al.: Laparoscopic management of ovarian tumors. Surg Endosc 1998, 12:1326–1333.
23. 23. U Ulrich W Paulus A Schneider 2000 Laparoscopic surgery for complex ovarian masses J Am Assoc Gynecol Laparosc 7 373 380 10924632 10.1016/S1074-3804(05)60481-1 1:STN:280:DC%2BD3cvptlynsQ%3D%3D Ulrich U, Paulus W, Schneider A, et al.: Laparoscopic surgery for complex ovarian masses. J Am Assoc Gynecol Laparosc 2000, 7:373–380.
24. 24. PS Liu DM Gershenson MW Bevers 1999 The current status of surgical staging of ovarian serous borderline tumors Cancer 85 905 911 10.1002/(SICI)1097-0142(19990215)85:4<905::AID-CNCR19>3.0.CO;2-8 Liu PS, Gershenson DM, Bevers MW, et al.: The current status of surgical staging of ovarian serous borderline tumors. Cancer 1999, 85:905–911.
25. 25. DM Gershenson EG Silva G Tortolero-Luna 1998 Serous borderline tumors of the ovary with noninvasive peritoneal implants Cancer 83 2157 2163 9827720 10.1002/(SICI)1097-0142(19981115)83:10<2157::AID-CNCR14>3.0.CO;2-D 1:STN:280:DyaK1M%2FktlChsA%3D%3D Gershenson DM, Silva EG, Tortolero-Luna G, et al.: Serous borderline tumors of the ovary with noninvasive peritoneal implants. Cancer 1998, 83:2157–2163.
26. 26. J Kaern CG Trope VM Abeler 1993 A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities Cancer 71 1810 1820 8383580 10.1002/1097-0142(19930301)71:5<1810::AID-CNCR2820710516>3.0.CO;2-V 1:STN:280:DyaK3s7ptlSksQ%3D%3D Kaern J, Trope CG, Abeler VM, et al.: A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities. Cancer 1993, 71:1810–1820.
27. 27. RT Morris DM Gershenson EG Silva 2000 Outcome and reproductive function after conservative surgery for borderline ovarian tumors Obstet Gynecol 95 541 547 10725486 10.1016/S0029-7844(99)00619-5 1:STN:280:DC%2BD3c7pt1Wjtw%3D%3D Morris RT, Gershenson DM, Silva EG, et al.: Outcome and reproductive function after conservative surgery for borderline ovarian tumors. Obstet Gynecol 2000, 95:541–547.
28. 28. WH Gotlieb S Flikker B Davidson 1998 Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome Cancer 82 141 146 9428490 10.1002/(SICI)1097-0142(19980101)82:1<141::AID-CNCR17>3.0.CO;2-2 1:STN:280:DyaK1c%2FovVOltA%3D%3D Gotlieb WH, Flikker S, Davidson B, et al.: Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome. Cancer 1998, 82:141–146.
29. 29. DR Barnhill RJ Kurman MF Brady 1995 Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study J Clin Oncol 13 2752 2756 7595734 1:STN:280:DyaK28%2FmslagsQ%3D%3D Barnhill DR, Kurman RJ, Brady MF, et al.: Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study. J Clin Oncol 1995, 13:2752–2756.
30. 30. RR Barakat I Benjamin JL Lewis 1995 Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potential Gynecol Oncol 59 390 393 8522261 10.1006/gyno.1995.9956 1:CAS:528:DyaK28XotVSksg%3D%3D Barakat RR, Benjamin I, Lewis JL Jr, et al.: Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potential. Gynecol Oncol 1995, 59:390–393.
31. 31. C Trope J Kaern I Vergote 1993 Are borderline tumors of the ovary overtreated both surgically and system-ically: a review of four prospective randomized trials including 253 patients with borderline tumors Gynecol Oncol 51 236 243 8276300 10.1006/gyno.1993.1279 1:STN:280:DyaK2c7gt1Kjug%3D%3D Trope C, Kaern J, Vergote I, et al.: Are borderline tumors of the ovary overtreated both surgically and system-ically: a review of four prospective randomized trials including 253 patients with borderline tumors. Gynecol Oncol 1993, 51:236–243.
32. 32. DM Gershenson M Deavers S Diaz 1999 Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors Clin Cancer Res 5 4053 4058 10632339 1:STN:280:DC%2BD3c%2Fps1ajsg%3D%3D Gershenson DM, Deavers M, Diaz S, et al.: Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors. Clin Cancer Res 1999, 5:4053–4058.